Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 1437 resultados

MENTOR: Maintenance of platelet homeostasis by tyrosine phosphatases and vascular heparan sulfates INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: ERC-2023-ADG Platelets are highly reactive fragments of megakaryocytes (MKs) that have been implicated in all major pathophysiological processes, but the...
2025-09-01 - 2030-08-31 | Financiado

ENTRY-DM: Interdisciplinary doctoral training on oligonucleotide-based therapies for myotonic dystrophy INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-DN-01 Rare diseases, though individually infrequent, collectively pose important challenges for patients, clinicians and researchers in terms of d...
2025-03-01 - 2029-02-28 | Financiado

THERABOT: Therapeutic Bacteria Biohybrids For Oncology Treatment INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-SE-01 THERABOT pioneers a groundbreaking approach in the fight against cancer through the development of engineered biohybrid agents, iBots. These...
2025-01-01 - 2028-12-31 | Financiado

SUITEX: A completely biological and human tissue engineered sling produced from Cell Assembled extracellular... INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: ERC-2024-POC Stress Urinary Incontinence (SUI) is a major medical issue affecting 1 in 5 women. Implantation of synthetic slings, made of knitted plastic...
2024-10-16 - 2026-06-30 | Financiado

PICKED: PersonalIzed medicine in Chronic KidnEy Disease INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-DN-01 In 2017, on a world scale the total number of individuals with chronic kidney disease, acute kidney injury, and those on renal replacement t...
2024-10-01 - 2028-09-30 | Financiado

Accelerate.EU: Elevating the Future of Cancer care with Alpha Theranostics INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE participó en un HORIZON EUROPE: HORIZON-JU-IHI-2023-05 Accelerate.EU, a collaborative European initiative, envisions revolutionising theranostics through innovative targeted alpha-therapies (TATs...
2024-09-11 - 2029-09-30 | Financiado

IMMCEPTION 2: Development of a new therapeutic product targeting neuroimmune circuits to treat asthma INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: ERC-2024-POC Asthma affects approximately 3% of the population and results in 1,000 daily deaths. It is characterized by chronic lung inflammation and ai...
2024-09-01 - 2026-02-28 | Financiado

ERDERA: EUROPEAN RARE DISEASES RESEARCH ALLIANCE INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-07 The European Rare Diseases Research Alliance (ERDERA) aims to improve the health and well-being of the 30 million people living with a rare...
2024-09-01 - 2031-08-31 | Financiado

ERDERA: EUROPEAN RARE DISEASES RESEARCH ALLIANCE INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-07 The European Rare Diseases Research Alliance (ERDERA) aims to improve the health and well-being of the 30 million people living with a rare...
2024-08-20 - 2031-08-31 | Financiado

IMMCEPTION 2: Development of a new therapeutic product targeting neuroimmune circuits to treat asthma INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: ERC-2024-POC Asthma affects approximately 3% of the population and results in 1,000 daily deaths. It is characterized by chronic lung inflammation and ai...
2024-08-06 - 2026-02-28 | Financiado

PLUMAGE: Embryonic control of trends and variation in avian colour patterns INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE participó en un HORIZON EUROPE: ERC-2023-ADG Most animals display striking patterns (i.e., spatial arrangement of characters in typical geometries). Natural patterns vary extensively, b...
2024-07-25 - 2029-12-31 | Financiado

MENTOR: Maintenance of platelet homeostasis by tyrosine phosphatases and vascular heparan sulfates INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un HORIZON EUROPE: ERC-2023-ADG Platelets are highly reactive fragments of megakaryocytes (MKs) that have been implicated in all major pathophysiological processes, but the...
2024-07-22 - 2030-08-31 | Financiado

T-RAFIC: Training network for tracking and controlling therapeutic immune cells in cancer Cancer immunotherapies have been established in a growing number of clinical indications and the pace of development is massively accelerat...
2024-07-16 - 2029-03-31 | Financiado

THERABOT: Therapeutic Bacteria Biohybrids For Oncology Treatment THERABOT pioneers a groundbreaking approach in the fight against cancer through the development of engineered biohybrid agents, iBots. These...
2024-07-02 - 2028-12-31 | Financiado

IDPfun2: Integrating novel data artificial intelligence and molecular behaviour to expand functional charact... INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE participó en un HORIZON EUROPE: HORIZON-MSCA-2023-SE-01 Nearly two decades ago, the unveiling of intrinsically disordered proteins/regions (IDPs/IDRs) disrupted the longstanding structure-function...
2024-07-01 - 2028-09-30 | Financiado

MIRACLE: Integrated multi angle research and training network to eradicate leukemia minimal residual disease An estimated 300,000 new cases of leukemia are diagnosed each year globally. The most common form of acute leukemia is acute myeloid leukemi...
2024-06-28 - 2028-11-30 | Financiado

INSERM